Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
“Digital transformation is now front and center of all life sciences companies’ thinking,” says Nagaraja Srivatsan, IQVIA's Senior Vice President and Chief Digital Officer of R&DS Technology ...
IQVIA’s new technologies are changing clinical trials, reducing the administrative burden on staff and improving insights for sponsors. Greg Lever, Director within the IQVIA Applied Data Science ...
IQVIA CEO Ari Bousbib said he expects these program reprioritizations to wrap up by the end of 2024. The company expects its contract research and technology & analytics solutions segments to grow ...
Durham, North Carolina-based IQVIA Holdings Inc. (IQV) provides advanced analytics, technology solutions, and clinical research services to the life sciences industry. It operates through ...
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments ...
the firm expects it to benefit from its sizable backlog and new technology offerings, the analyst tells investors in a research note. Based on Iqvia’s industry leadership, revenue visibility ...
Narrow-moat Iqvia delivered solid third-quarter results, highlighted by revenue of nearly $3.9 billion representing 4% growth versus the prior year. The technology and analytics solutions ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
IQVIA Holdings Inc. price-eps-surprise | IQVIA ... The top line is likely to have been driven by increased revenues across the Technology and Analytics segment (TAS), and Research and Development ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...